n-n-propylnorapomorphine has been researched along with morphine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agnati, L; Dafeldecker, WP; Fuxe, K; Guarino, J; Kosersky, DS; Neumeyer, JL; Reinhard, JF | 1 |
Bhargava, HN; Das, S | 1 |
Martin, JR; Takemori, AE | 1 |
Baggio, G; Ferrari, F | 1 |
Aston-Jones, G; Druhan, JP; Walters, CL | 2 |
6 other study(ies) available for n-n-propylnorapomorphine and morphine
Article | Year |
---|---|
Aporphines. 14 Dopaminergic and antinociceptive activity of aporphine derivatives. Synthesis of 10-hydroxyaporphines and 10-hydroxy-N-n-propylnoraporphine.
Topics: Analgesics; Animals; Aporphines; Dopamine; Humans; Male; Mice; Neural Pathways; Rats; Reaction Time; Stereotyped Behavior; Structure-Activity Relationship | 1976 |
Effect of chronic treatment with morphine on the binding of 3H-N-n-propylnorapomorphine to striatal membranes of rats: influence of prolyl-leucyl-glycinamide.
Topics: Animals; Antiparkinson Agents; Apomorphine; beta-Endorphin; Corpus Striatum; Drug Tolerance; Endorphins; Kinetics; Male; Membranes; Morphine; MSH Release-Inhibiting Hormone; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1985 |
Increased sensitivity to dopamine agonists following a single dose of morphine or levorphanol in mice.
Topics: Animals; Apomorphine; Brain; Brain Stem; Cerebral Cortex; Chlorides; Corpus Striatum; Dextrorphan; Drug Synergism; Hippocampus; Levorphanol; Lithium; Lithium Chloride; Male; Mice; Morphine; Motor Activity; Naloxone; Narcotics; Receptors, Dopamine; Spiperone | 1985 |
Potentiation of the aphrodisiac effect of N-n-propyl-norapomorphine by naloxone.
Topics: Adrenocorticotropic Hormone; Animals; Aphrodisiacs; Apomorphine; Dose-Response Relationship, Drug; Drug Synergism; Male; Morphine; Naloxone; Rats; Rats, Inbred Strains | 1982 |
Behavioral activation induced by D(2)-like receptor stimulation during opiate withdrawal.
Topics: Analgesics, Opioid; Animals; Apomorphine; Behavior, Animal; Dopamine Agonists; Dopamine Antagonists; Drug Synergism; Locomotion; Male; Morphine; Morphine Dependence; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stereotyped Behavior; Substance Withdrawal Syndrome | 2000 |
Expression of fos-related antigens in the nucleus accumbens during opiate withdrawal and their attenuation by a D2 dopamine receptor agonist.
Topics: Animals; Apomorphine; Behavior, Animal; Dopamine Agonists; Dopamine Antagonists; Immunohistochemistry; Lithium Chloride; Male; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Nucleus Accumbens; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Substance Withdrawal Syndrome | 2000 |